Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation

The tumor resistance to p53 activators posed a clinical challenge. Combination studies disclosed that concomitant administration of Bcl2 inhibitors can sensitize the tumor cells and induce apoptosis. In this study, we utilized a rapid synthetic route to synthesize two novel hybrid spirooxindole-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz, Yasmine M. Abdel, Lotfy, Gehad, Said, Mohamed M., El Ashry, El Sayed H., El Tamany, El Sayed H., Soliman, Saied M., Abu-Serie, Marwa M., Teleb, Mohamed, Yousuf, Sammer, Dömling, Alexander, Domingo, Luis R., Barakat, Assem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713455/
https://www.ncbi.nlm.nih.gov/pubmed/34970530
http://dx.doi.org/10.3389/fchem.2021.735236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713455/
https://www.ncbi.nlm.nih.gov/pubmed/34970530
http://dx.doi.org/10.3389/fchem.2021.735236

Ejemplares similares